PubRank

Sheila A Shurtleff

Author PubWeight™ 112.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007 17.68
2 Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002 11.83
3 Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009 10.54
4 BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008 10.12
5 The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012 9.89
6 Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008 9.25
7 Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003 4.54
8 Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009 4.43
9 Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010 4.09
10 Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004 3.77
11 The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 2013 3.43
12 Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A 2009 1.92
13 Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia. J Clin Oncol 2011 1.52
14 Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. Br J Haematol 2003 1.41
15 Genetic analysis of patients with defects in early B-cell development. Immunol Rev 2005 1.41
16 ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003 1.36
17 An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. Br J Haematol 2008 1.33
18 Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol 2012 1.30
19 Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer 2003 1.25
20 Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 2004 1.17
21 Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002 1.05
22 Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 2006 0.99
23 MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas. Acta Neuropathol 2010 0.96
24 Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther 2012 0.94
25 Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum Mutat 2005 0.92
26 Near-triploidy and near-tetraploidy in childhood acute lymphoblastic leukemia: association with B-lineage blast cells carrying the ETV6-RUNX1 fusion, T-lineage immunophenotype, and favorable outcome. Cancer Genet Cytogenet 2006 0.89
27 Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital. Pediatr Dev Pathol 2002 0.86
28 Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. Br J Haematol 2014 0.84
29 Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 2014 0.84
30 Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. Clin Immunol 2011 0.82
31 Incidental diagnosis of diffuse intrinsic pontine glioma in children. Pediatr Blood Cancer 2015 0.75